<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">672</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2023-22-3-68-73</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en"><italic>Helicobacter pylori</italic> infection in children with immune thrombocytopenia</article-title><trans-title-group xml:lang="ru"><trans-title><italic>Helicobacter pylori</italic> infection in children with immune thrombocytopenia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ragab</surname><given-names>S. M.</given-names></name><address><country country="EG">Egypt</country></address><bio xml:lang="en"><p>Seham M. Ragab</p><p>Menoufia</p></bio><bio xml:lang="ru"><p>Menoufia</p></bio><email>seham@yahoo.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>El-Hawy</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>El-Hawy</surname><given-names>M. А.</given-names></name></name-alternatives><address><country country="EG">Egypt</country></address><bio xml:lang="en"><p>Mahmoud A. El-Hawy</p><p>Menoufia</p></bio><bio xml:lang="ru"><p>Mahmoud Ahmed El-Hawy - Department of Pediatrics, Faculty of Medicine</p><p>Shebin El Kom, 32511 Menoufia</p></bio><email>mahmodelhawy18@yahoo.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Awad</surname><given-names>S. M.</given-names></name><address><country country="EG">Egypt</country></address><bio xml:lang="en"><p>Samah M. Awad</p><p>Menoufia</p></bio><bio xml:lang="ru"><p>Menoufia</p></bio><email>Samah@yahoo.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Soliman</surname><given-names>W. A.</given-names></name><name xml:lang="ru"><surname>Soliman</surname><given-names>W.A.</given-names></name></name-alternatives><address><country country="EG">Egypt</country></address><bio xml:lang="en"><p>Walaa Alaa Soliman</p><p>Menoufia</p></bio><bio xml:lang="ru"><p>Menoufia</p></bio><email>Walaa@yahoo.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Mahmoud</surname><given-names>A. A.</given-names></name><address><country country="EG">Egypt</country></address><bio xml:lang="en"><p>Asmaa A. Mahmoud</p><p>Menoufia</p></bio><bio xml:lang="ru"><p>Menoufia</p></bio><email>Asma@yahoo.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>Menoufia University</institution></aff><aff-alternatives id="aff2"><aff><institution xml:lang="en">Department of Pediatrics, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.</institution></aff><aff><institution xml:lang="ru">Menoufia University</institution></aff></aff-alternatives><aff id="aff3"><institution>National Liver Institute, Menoufia University</institution></aff><pub-date date-type="pub" iso-8601-date="2023-10-03" publication-format="electronic"><day>03</day><month>10</month><year>2023</year></pub-date><volume>22</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>68</fpage><lpage>73</lpage><history><date date-type="received" iso-8601-date="2022-12-30"><day>30</day><month>12</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-03-23"><day>23</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/672">https://hemoncim.com/jour/article/view/672</self-uri><abstract xml:lang="en"><p>To detect the association between Helicobacter pylori (H. pylori) infection and immune thrombocytopenia in children and adolescents. Immune thrombocytopenia (ITP) is a common bleeding disorder in childhood. H. pylori is a widespread organism that is present in about 50% of the global population. There is an obvious relation between helicobacter pylori infection and chronic idiopathic thrombocytopenic purpura. A cross-sectional study was conducted in 95 patients with ITP who were recruited from the Hematology Unit, Department of Pediatrics, Menoufia University Hospital in the period from June 2021 to June 2022. The age of the patients ranged between 3.5 and 7.5 years. Fifty-five of them were males and 40 were females. The study was approved by the Ethical Committee of the Faculty of Medicine, Menoufia University. Out of the studied ITP children, 62 (65.3%) were positive for H. pylori antigen in stool, and 33 (34.7%) were negative. There was a significant difference between H. pylori-positive and H. pylori-negative patients regarding the grade of bleeding at presentation; 51 (82.3%) H. pylori-positive patients presented with grade 3 bleeding, 35 (56.5%) of them presented with skin and gum bleeding, 16 (25.8%) presented with skin bleeding and epistaxis. There was a statistically significant difference in the rate of recovery between H. pylorinegative patients (78.8%) and H. pylori-positive patients (22.6%). There was a significant rise in the platelet count in H. pylori-positive patients after the treatment of H. pylori. The prevalence of H. pylori infection in ITP pediatric patients was 65.3%. There was a significant rise in the platelet count in H. pylori-positive ITP children after the treatment of H. pylori.</p></abstract><trans-abstract xml:lang="ru"><p>To detect the association between Helicobacter pylori (H. pylori) infection and immune thrombocytopenia in children and adolescents. Immune thrombocytopenia (ITP) is a common bleeding disorder in childhood. H. pylori is a widespread organism that is present in about 50% of the global population. There is an obvious relation between helicobacter pylori infection and chronic idiopathic thrombocytopenic purpura. A cross-sectional study was conducted in 95 patients with ITP who were recruited from the Hematology Unit, Department of Pediatrics, Menoufia University Hospital in the period from June 2021 to June 2022. The age of the patients ranged between 3.5 and 7.5 years. Fifty-five of them were males and 40 were females. The study was approved by the Ethical Committee of the Faculty of Medicine, Menoufia University. Out of the studied ITP children, 62 (65.3%) were positive for H. pylori antigen in stool, and 33 (34.7%) were negative. There was a significant difference between H. pylori-positive and H. pylori-negative patients regarding the grade of bleeding at presentation; 51 (82.3%) H. pylori-positive patients presented with grade 3 bleeding, 35 (56.5%) of them presented with skin and gum bleeding, 16 (25.8%) presented with skin bleeding and epistaxis. There was a statistically significant difference in the rate of recovery between H. pylorinegative patients (78.8%) and H. pylori-positive patients (22.6%). There was a significant rise in the platelet count in H. pylori-positive patients after the treatment of H. pylori. The prevalence of H. pylori infection in ITP pediatric patients was 65.3%. There was a significant rise in the platelet count in H. pylori-positive ITP children after the treatment of H. pylori.</p></trans-abstract><kwd-group xml:lang="en"><kwd>children</kwd><kwd>Helicobacter pylori</kwd><kwd>immune thrombocytopenia</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>children</kwd><kwd>Helicobacter pylori</kwd><kwd>immune thrombocytopenia</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Not specified</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Ikuse T., Toda M., Kashiwagi K., Maruyama K., Nagata M., Tokushima K., et al. Efficacy of Helicobacter pylori Eradication Therapy on Platelet Recovery in Pediatric Immune Thrombocytopenic Purpura-Case Series and a Systematic Review. Microorganisms 2020; 8 (10): 1457.</mixed-citation><mixed-citation xml:lang="ru">Ikuse T., Toda M., Kashiwagi K., Maruyama K., Nagata M., Tokushima K., et al. Efficacy of Helicobacter pylori Eradication Therapy on Platelet Recovery in Pediatric Immune Thrombocytopenic Purpura-Case Series and a Systematic Review. Microorganisms 2020; 8 (10): 1457.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Kim B.J., Kim H.S., Jang H.J., Kim J.H. Helicobacter pylori eradication in idiopathic thrombocytopenic purpura: a meta-analysis of randomized trials. Gastroenterol Res Pract 2018; 2018: 6090878, 1–8.</mixed-citation><mixed-citation xml:lang="ru">Kim B.J., Kim H.S., Jang H.J., Kim J.H. Helicobacter pylori eradication in idiopathic thrombocytopenic purpura: a meta-analysis of randomized trials. Gastroenterol Res Pract 2018; 2018: 6090878, 1–8.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. D’Orazio J.A., Neely J., Farhoudi N. ITP in Children. J Pediatr Hematol Oncol 2013; 35: 1–13.</mixed-citation><mixed-citation xml:lang="ru">D’Orazio J.A., Neely J., Farhoudi N. ITP in Children. J Pediatr Hematol Oncol 2013; 35: 1–13.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Consolini R., Renee Forbes L., Wahlstrom J., Pignata C., Giardino G., Gallo V. Unbalanced immune system: immunodeficiencies and autoimmunity. Front Paediatr 2016; 4: 1–9.</mixed-citation><mixed-citation xml:lang="ru">Consolini R., Renee Forbes L., Wahlstrom J., Pignata C., Giardino G., Gallo V. Unbalanced immune system: immunodeficiencies and autoimmunity. Front Paediatr 2016; 4: 1–9.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Ghanima W., Godeau B., Cines D.B., Bussel J.B. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood 2012; 120 (5): 960–9.</mixed-citation><mixed-citation xml:lang="ru">Ghanima W., Godeau B., Cines D.B., Bussel J.B. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood 2012; 120 (5): 960–9.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Mentis A., Lehours P., Mégraud F. Epidemiology and Diagnosis of Helicobacter pylori infection. Helicobacter 2015; 20: 1–7.</mixed-citation><mixed-citation xml:lang="ru">Mentis A., Lehours P., Mégraud F. Epidemiology and Diagnosis of Helicobacter pylori infection. Helicobacter 2015; 20: 1–7.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Eghbali A., Siavashan V.R., Bagheri B., Afzal R.R. Impact of Helicobacter pylori Eradication in Children with Acute Immune Thrombocytopenia: A Randomized Controlled Study. Arch Pediatr Infect Dis 2019; (7): 98–102.</mixed-citation><mixed-citation xml:lang="ru">Eghbali A., Siavashan V.R., Bagheri B., Afzal R.R. Impact of Helicobacter pylori Eradication in Children with Acute Immune Thrombocytopenia: A Randomized Controlled Study. Arch Pediatr Infect Dis 2019; (7): 98–102.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Frydman G.H., Davis N., Beck P.L., Fox J.G. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography. Helicobacter 2015; 20 (4): 239–51.</mixed-citation><mixed-citation xml:lang="ru">Frydman G.H., Davis N., Beck P.L., Fox J.G. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography. Helicobacter 2015; 20 (4): 239–51.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Hodeib M.M., Ali A.G., Kamel N.M., Senosy S.A., Fahmy E.M., Abdelsadik A., et al. Impact of eradication therapy of Helicobacter pylori in children with chronic immune thrombocytopenic purpura. Egyptian Pediatric Association Gazette 2021; 69 (1): 1–4.</mixed-citation><mixed-citation xml:lang="ru">Hodeib M.M., Ali A.G., Kamel N.M., Senosy S.A., Fahmy E.M., Abdelsadik A., et al. Impact of eradication therapy of Helicobacter pylori in children with chronic immune thrombocytopenic purpura. Egyptian Pediatric Association Gazette 2021; 69 (1): 1–4.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Abdollahi A., Shoar S., Ghasemi S., Zohreh O.Y. Is Helicobacter pylori infection a risk factor for idiopathic thrombocytopenic purpura in children? Ann Afr Med 2015; 14 (4): 177–81.</mixed-citation><mixed-citation xml:lang="ru">Abdollahi A., Shoar S., Ghasemi S., Zohreh O.Y. Is Helicobacter pylori infection a risk factor for idiopathic thrombocytopenic purpura in children? Ann Afr Med 2015; 14 (4): 177–81.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Akbayram S., Dogan M., Ustyol L., Akgun C., Peker E., Bilici S., et al. The clinical outcome of 260 pediatric ITP patients in one center. Clin Appl Thromb Hemost 2011; 17 (6): E30–5.</mixed-citation><mixed-citation xml:lang="ru">Akbayram S., Dogan M., Ustyol L., Akgun C., Peker E., Bilici S., et al. The clinical outcome of 260 pediatric ITP patients in one center. Clin Appl Thromb Hemost 2011; 17 (6): E30–5.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Zafar H., Anwar S., Faizan M., Riaz S. Clinical features and outcome in paediatric newly diagnosed immune thrombocytopenic purpura in a tertiary care centre. Pak J Med Sci 2018; 34 (5): 1195–9.</mixed-citation><mixed-citation xml:lang="ru">Zafar H., Anwar S., Faizan M., Riaz S. Clinical features and outcome in paediatric newly diagnosed immune thrombocytopenic purpura in a tertiary care centre. Pak J Med Sci 2018; 34 (5): 1195–9.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Bennett C.M., Neunert C., Grace R.F., Buchanan G., Imbach P., Vesely S.K., et al. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. Pediatr Blood Cancer 2018; 65 (1): e26736.</mixed-citation><mixed-citation xml:lang="ru">Bennett C.M., Neunert C., Grace R.F., Buchanan G., Imbach P., Vesely S.K., et al. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. Pediatr Blood Cancer 2018; 65 (1): e26736.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Hooi J.K.Y., Lai W.Y., Ng W.K., Suen M.M.Y., Underwood F.E., Tanyingoh D., et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology 2017; 153 (2): 420–9. DOI: 10.1053/j. gastro.2017.04.022</mixed-citation><mixed-citation xml:lang="ru">Hooi J.K.Y., Lai W.Y., Ng W.K., Suen M.M.Y., Underwood F.E., Tanyingoh D., et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology 2017; 153 (2): 420–9. DOI: 10.1053/j. gastro.2017.04.022</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Ahmed A.Z., Radwan A.M., Rizk H.L. The Role of Helicobacter Pylori Infection in Idiopathic Thrombocytopenic Purpura in Children. Egyptian Journal of Hospital Medicine 2021; 82 (2): 193–8.</mixed-citation><mixed-citation xml:lang="ru">Ahmed A.Z., Radwan A.M., Rizk H.L. The Role of Helicobacter Pylori Infection in Idiopathic Thrombocytopenic Purpura in Children. Egyptian Journal of Hospital Medicine 2021; 82 (2): 193–8.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Jaing T.H., Tsay P.K., Hung I.J., Chiu C.H., Yang C.P., Huang I.A. The role of Helicobacter pylori infection in children with acute immune thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47 (2): 215–7.</mixed-citation><mixed-citation xml:lang="ru">Jaing T.H., Tsay P.K., Hung I.J., Chiu C.H., Yang C.P., Huang I.A. The role of Helicobacter pylori infection in children with acute immune thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47 (2): 215–7.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Cheng Y.Y., Xiong H., Xu Z.L., Li J.X., Li H., Cai W., et al. Association between Helicobacter pylori infection and newly diagnosed childhood immune thrombocytopenia. Zhongguo Dang Dai Er Ke Za Zhi 2015; 17 (1): 22–5.</mixed-citation><mixed-citation xml:lang="ru">Cheng Y.Y., Xiong H., Xu Z.L., Li J.X., Li H., Cai W., et al. Association between Helicobacter pylori infection and newly diagnosed childhood immune thrombocytopenia. Zhongguo Dang Dai Er Ke Za Zhi 2015; 17 (1): 22–5.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Stasi R., Sarpatwari A., Segal J.B., Osborn J., Evangelista M.L., Cooper N., et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009; 113 (6): 1231–40.</mixed-citation><mixed-citation xml:lang="ru">Stasi R., Sarpatwari A., Segal J.B., Osborn J., Evangelista M.L., Cooper N., et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009; 113 (6): 1231–40.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Noonavath R.N., Lakshmi C.P., Dutta T.K., Kate V. Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura. World J Gastroenterol 2014; 20 (22): 6918–23.</mixed-citation><mixed-citation xml:lang="ru">Noonavath R.N., Lakshmi C.P., Dutta T.K., Kate V. Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura. World J Gastroenterol 2014; 20 (22): 6918–23.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Pezeshki S.M.S., Saki N., Ghandali	M.V., Ekrami A., Avarvand A.Y. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Res 2021; 56 (1): 38–43.</mixed-citation><mixed-citation xml:lang="ru">Pezeshki S.M.S., Saki N., Ghandali M.V., Ekrami A., Avarvand A.Y. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Res 2021; 56 (1): 38–43.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Franchini M., Cruciani M., Mengoli C., Pizzolo G., Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and metaanalysis. J Antimicrob Chemother 2007; 60: 237–46.</mixed-citation><mixed-citation xml:lang="ru">Franchini M., Cruciani M., Mengoli C., Pizzolo G., Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and metaanalysis. J Antimicrob Chemother 2007; 60: 237–46.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
